Eli Lilly and Company

04/06/2024 | Press release | Distributed by Public on 04/06/2024 07:52

Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a[...]